X
X T L Biopharmaceuticals Ltd
TASE:XTLB
X T L Biopharmaceuticals Ltd
TASE:XTLB
Price:
2.3
ILS
Market Closed
Market Cap:
₪21.8m
Income Statement
Earnings Waterfall
X T L Biopharmaceuticals Ltd
X T L Biopharmaceuticals Ltd
Income Statement
X T L Biopharmaceuticals Ltd
X T L Biopharmaceuticals Ltd
Currency: USD
| Dec-2008 | Mar-2009 | Jun-2009 | Sep-2009 | Dec-2009 | Mar-2010 | Jun-2010 | Sep-2010 | Dec-2010 | Mar-2011 | Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Jun-2016 | Dec-2016 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||||||||||||
| Revenue |
6
N/A
|
2
-65%
|
2
-2%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+176%
|
2
+71%
|
2
+32%
|
2
+6%
|
(0)
N/A
|
(1)
-6 700%
|
(1)
-19%
|
(1)
-22%
|
(1)
+41%
|
(1)
N/A
|
(1)
-66%
|
(1)
-30%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Gross Profit | |||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(2)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gross Profit |
4
N/A
|
2
-51%
|
2
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
1
+195%
|
1
+84%
|
1
+31%
|
1
+7%
|
0
N/A
|
0
N/A
|
1
N/A
|
0
-21%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | |||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(15)
|
(8)
|
(1)
|
2
|
3
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(3)
|
(4)
|
(5)
|
(5)
|
(0)
|
1
|
2
|
2
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Selling, General & Administrative |
(4)
|
(1)
|
2
|
4
|
2
|
0
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(1)
|
(0)
|
0
|
(0)
|
(2)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Research & Development |
(12)
|
(8)
|
(4)
|
(2)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
2
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(11)
N/A
|
(6)
+48%
|
1
N/A
|
2
+201%
|
3
+25%
|
1
-78%
|
(1)
N/A
|
(1)
-32%
|
(1)
N/A
|
(1)
+1%
|
(1)
+2%
|
(1)
-1%
|
(1)
+2%
|
(1)
-6%
|
(2)
-25%
|
(1)
+9%
|
(2)
-61%
|
(3)
-22%
|
(3)
-13%
|
(4)
-22%
|
(0)
+91%
|
(0)
+94%
|
0
N/A
|
1
+102%
|
(2)
N/A
|
(2)
+10%
|
(2)
+12%
|
(2)
+5%
|
(2)
-26%
|
(2)
+19%
|
(1)
+50%
|
(0)
+64%
|
(0)
-69%
|
(1)
-37%
|
(1)
-28%
|
(1)
+8%
|
(1)
N/A
|
(1)
-3%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
1
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
0
|
1
|
2
|
3
|
4
|
3
|
3
|
|
| Non-Reccuring Items |
(8)
|
(8)
|
(8)
|
(8)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(2)
|
(2)
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
1
|
|
| Pre-Tax Income |
(18)
N/A
|
(13)
+28%
|
(7)
+48%
|
(6)
+18%
|
3
N/A
|
1
-78%
|
(1)
N/A
|
(1)
-31%
|
(1)
-1%
|
(1)
+3%
|
(1)
+3%
|
(1)
-4%
|
(1)
+2%
|
(1)
-6%
|
(2)
-31%
|
(1)
+11%
|
(2)
-56%
|
(3)
-23%
|
(3)
-11%
|
(5)
-50%
|
(0)
+94%
|
0
N/A
|
0
+1 400%
|
1
+387%
|
(2)
N/A
|
(2)
-1%
|
(2)
+12%
|
(2)
+7%
|
(4)
-95%
|
(3)
+16%
|
(2)
+45%
|
0
N/A
|
1
N/A
|
1
+3%
|
2
+113%
|
3
+54%
|
6
+100%
|
3
-48%
|
|
| Net Income | |||||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(18)
|
(13)
|
(7)
|
(6)
|
3
|
1
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(5)
|
(0)
|
0
|
0
|
1
|
(2)
|
(2)
|
(2)
|
(2)
|
(4)
|
(3)
|
(2)
|
0
|
1
|
1
|
2
|
3
|
6
|
3
|
|
| Income to Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Equity Earnings Affiliates |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Income (Common) |
(18)
N/A
|
(13)
+29%
|
(7)
+49%
|
(6)
+19%
|
3
N/A
|
1
-77%
|
(1)
N/A
|
(1)
-32%
|
(1)
-2%
|
(1)
+3%
|
(1)
+3%
|
(1)
-4%
|
(1)
+2%
|
(1)
-6%
|
(2)
-31%
|
(1)
+17%
|
(1)
-1%
|
(2)
-36%
|
(2)
-17%
|
(3)
-21%
|
(2)
+8%
|
(2)
+7%
|
(2)
+19%
|
(2)
+1%
|
(3)
-38%
|
(3)
-15%
|
(3)
+4%
|
(3)
+3%
|
(4)
-59%
|
(3)
+24%
|
(2)
+49%
|
0
N/A
|
1
N/A
|
1
+3%
|
2
+113%
|
3
+54%
|
6
+100%
|
3
-48%
|
|
| EPS (Diluted) |
-15.75
N/A
|
-11.26
+29%
|
-5.79
+49%
|
-4.71
+19%
|
2.21
N/A
|
0.53
-76%
|
-0.75
N/A
|
-0.43
+43%
|
-0.4
+7%
|
-0.41
-2%
|
-0.21
+49%
|
-0.37
-76%
|
-0.3
+19%
|
-0.35
-17%
|
-0.37
-6%
|
-0.32
+14%
|
-0.03
+91%
|
-0.04
-33%
|
-0.04
N/A
|
-0.07
-75%
|
-0.05
+29%
|
-0.05
N/A
|
-0.04
+20%
|
-0.04
N/A
|
-0.05
-25%
|
-0.04
+20%
|
-0.03
+25%
|
-0.06
-100%
|
-0.07
-17%
|
-0.07
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0.01
N/A
|
0.01
N/A
|
0.01
N/A
|
|
Switch to:
Switch to:
See Also
Discover More
